NASDAQ:IIVI - II-VI Stock Price, Forecast & News

II-VI trades on the NASDAQ under the ticker symbol "IIVI."

II-VI, Inc. (NASDAQ:IIVI) issued its earnings results on Monday, February, 10th. The scientific and technical instruments company reported $0.36 EPS for the quarter, hitting the consensus estimate of $0.36. The scientific and technical instruments company earned $666.30 million during the quarter, compared to analysts' expectations of $610.30 million. II-VI had a negative return on equity of 4.44% and a negative net margin of 4.18%. II-VI's quarterly revenue was up 94.3% compared to the same quarter last year. During the same period last year, the business earned $0.71 earnings per share. View II-VI's Earnings History.

II-VI is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for II-VI.

II-VI issued an update on its third quarter earnings guidance on Monday, February, 10th. The company provided EPS guidance of $0.02-0.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.39. The company issued revenue guidance of $550-600 million, compared to the consensus revenue estimate of $616.17 million.

15 Wall Street analysts have issued 12-month target prices for II-VI's stock. Their forecasts range from $30.00 to $53.00. On average, they expect II-VI's share price to reach $41.31 in the next year. This suggests a possible upside of 13.1% from the stock's current price. View Analyst Price Targets for II-VI.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for II-VI in the last year. There are currently 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for II-VI.

News coverage about IIVI stock has trended neutral recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. II-VI earned a news impact score of 0.5 on InfoTrie's scale. They also assigned media headlines about the scientific and technical instruments company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for II-VI.

Some companies that are related to II-VI include Emerson Electric (EMR), Eaton (ETN), Roper Technologies (ROP), Rockwell Automation (ROK), AMETEK (AME), Generac (GNRC), Enphase Energy (ENPH), Acuity Brands (AYI), Regal Beloit (RBC), EnerSys (ENS), Brady (BRC), Franklin Electric (FELE), Belden (BDC), Vicor (VICR) and Encore Wire (WIRE).

Based on aggregate information from My MarketBeat watchlists, some companies that other II-VI investors own include NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Lumentum (LITE), Verizon Communications (VZ), Netflix (NFLX), Tesla (TSLA), CVS Health (CVS), Advanced Micro Devices (AMD) and Editas Medicine (EDIT).

II-VI's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (3.00%), Barrow Hanley Mewhinney & Strauss LLC (2.63%), Robecosam AG (1.89%), Robecosam AG (1.89%), Iridian Asset Management LLC CT (1.53%) and Franklin Resources Inc. (1.46%). Company insiders that own II-VI stock include Christopher Koeppen, David G Wagner, Francis J Kramer, Howard H Xia, Joseph J Corasanti, Marc Y E Pelaez, Mary Jane Raymond, Shaker Sadasivam and Vincent D Mattera Jr. View Institutional Ownership Trends for II-VI.

IIVI stock was sold by a variety of institutional investors in the last quarter, including Mason Street Advisors LLC, DNB Asset Management AS, State of New Jersey Common Pension Fund D, Principal Financial Group Inc., Victory Capital Management Inc., Victory Capital Management Inc., State Street Corp and Falcon Point Capital LLC. Company insiders that have sold II-VI company stock in the last year include Christopher Koeppen, David G Wagner, Francis J Kramer, Howard H Xia, Marc Y E Pelaez, Mary Jane Raymond and Vincent D Mattera Jr. View Insider Buying and Selling for II-VI.

IIVI stock was bought by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Franklin Resources Inc., Mariner LLC, Barrow Hanley Mewhinney & Strauss LLC, Robecosam AG, Robecosam AG, Pinnacle Associates Ltd. and Snow Capital Management LP. Company insiders that have bought II-VI stock in the last two years include Joseph J Corasanti and Shaker Sadasivam. View Insider Buying and Selling for II-VI.

Shares of IIVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IIVI stock can currently be purchased for approximately $36.53.

II-VI has a market capitalization of $3.33 billion and generates $1.36 billion in revenue each year. The scientific and technical instruments company earns $107.52 million in net income (profit) each year or $1.63 on an earnings per share basis. II-VI employs 12,487 workers across the globe.View Additional Information About II-VI.

The official website for II-VI is http://www.ii-vi.com/.

II-VI's mailing address is 375 SAXONBURG BOULEVARD, SAXONBURG PA, 16056. The scientific and technical instruments company can be reached via phone at 724-352-4455 or via email at [email protected]